Antibe Therapeutics (ATE) News Today → Mysterious Gold Leverage Just Announced (From Stansberry Research) (Ad) Free ATE Stock Alerts C$0.30 0.00 (0.00%) (As of 04/23/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider Trades All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineCanadian Investment Regulatory Organization Trading Halt - ATEfinance.yahoo.com - April 9 at 10:12 AMAntibe Announces Unfavorable Decision in Arbitration With Nuance Pharmafinance.yahoo.com - March 4 at 8:27 AMAntibe Therapeutics (TSE:ATE) Share Price Passes Above 50-Day Moving Average of $0.92marketbeat.com - February 9 at 4:40 AMAntibe Extends Early Warrant Exercise Incentive Programfinance.yahoo.com - February 1 at 10:39 AMAntibe Therapeutics Inc ATEmorningstar.com - December 31 at 10:25 AMAntibe Announces Early Warrant Exercise Incentive Programfinance.yahoo.com - December 29 at 7:27 AMAntibe Reports Q2 2024 Interim Financial and Operating Resultsfinance.yahoo.com - November 13 at 8:25 AMAntibe Therapeutics: Top 25 Performing Stocks Year-to-Date on Toronto Stock Exchange (ATE)theglobeandmail.com - November 8 at 8:41 PMHercules at 52-Week High on Barrick Hookupbaystreet.ca - November 6 at 2:59 PMAntibe at 52-Week High on Newsbaystreet.ca - November 1 at 1:08 PMAntibe Completes First Clinical Study of Otenaproxesul’s New Formulationfinance.yahoo.com - November 1 at 8:07 AMAntibe Initiates First Clinical Study of Otenaproxesul's New Formulationbenzinga.com - October 18 at 9:17 AMStocks in play: Antibe Therapeutics Inc.ca.finance.yahoo.com - September 28 at 12:58 PMAntibe Receives Approval to Initiate PK/PD Study of Otenaproxesulfinance.yahoo.com - September 28 at 7:58 AMAntibe Therapeutics Inc. (ATE)investing.com - September 6 at 8:58 PMToronto Stock Exchange, Antibe Therapeutics Inc., View From The C-Suitefinance.yahoo.com - August 21 at 4:00 PMToronto Stock Exchange, Antibe Therapeutics Inc., View From The C-Suitefinance.yahoo.com - August 21 at 4:00 PMClosing Bell: Antibe Therapeutics Inc down on Wednesday (ATE)theglobeandmail.com - August 17 at 4:37 AMAntibe Therapeutics Inc.'s (TSE:ATE) Path To Profitabilityfinance.yahoo.com - June 30 at 7:58 AMLast Week of June Looks Eventfulbaystreet.ca - June 23 at 8:06 PMBest Times To Visit Antibestravel.usnews.com - June 16 at 3:07 PMClosing Bell: Antibe Therapeutics Inc up on Monday (ATE)theglobeandmail.com - June 13 at 12:35 AMClosing Bell: Antibe Therapeutics Inc down on Friday (ATE)theglobeandmail.com - June 3 at 10:57 AMClosing Bell: Antibe Therapeutics Inc up on Thursday (ATE)theglobeandmail.com - May 19 at 5:54 PMClosing Bell: Antibe Therapeutics Inc flat on Thursday (ATE)theglobeandmail.com - April 28 at 3:58 AMAntibe’s Chief Medical Officer to Present at the 2023 Precision in Clinical Trials Summitfinance.yahoo.com - April 25 at 7:47 AMClosing Bell: Antibe Therapeutics Inc up on Tuesday (ATE)theglobeandmail.com - April 18 at 11:41 PMAntibe to Present at the 2023 Bloom Burton & Co. Healthcare Investor Conferencefinance.yahoo.com - April 18 at 8:40 AMClosing Bell: Antibe Therapeutics Inc down on Monday (ATE)theglobeandmail.com - April 17 at 10:04 PMClosing Bell: Antibe Therapeutics Inc flat on Friday (ATE)theglobeandmail.com - April 14 at 11:25 PMAntibe Provides April 2023 Corporate Updatefinance.yahoo.com - April 11 at 8:16 AMClosing Bell: Antibe Therapeutics Inc flat on Monday (ATE)theglobeandmail.com - April 11 at 1:40 AMClosing Bell: Antibe Therapeutics Inc down on Thursday (ATE)theglobeandmail.com - April 7 at 1:32 AMAntibe Reports Q3 2023 Interim Financial and Operating Resultsfinance.yahoo.com - February 15 at 8:04 AMAntibe Therapeutics: Top 25 Undervalued Toronto Stock Exchange Stocks (ATE)theglobeandmail.com - February 5 at 2:32 PMAntibe Reports Q2 2023 Interim Financial and Operating Resultsfinance.yahoo.com - November 15 at 10:54 AMAntibe Closes Previously Announced Strategic Sale of Citagenix Subsidiaryfinance.yahoo.com - November 2 at 9:23 AMAntibe Therapeutics: Top 10 Undervalued Medical Devices & Instruments Industry Stocks (ATE)theglobeandmail.com - November 1 at 10:39 PMAntibe Therapeutics: Bottom 25 Performing Stocks Year-to-Date on TSE (ATE)theglobeandmail.com - September 15 at 11:34 AMAntibe Therapeutics: Stocks trading at Less Than Cash Value on (ATE)theglobeandmail.com - September 12 at 11:36 PMATE.TO: Plans on Track for Acute Pain Program for Otenaproxesul…finance.yahoo.com - September 7 at 5:20 PMAntibe Therapeutics: Bottom 25 Performing Stocks Year-to-Date on Toronto Stock Exchange (ATE)theglobeandmail.com - August 18 at 12:40 PMAntibe Therapeutics Inc stock advanced on Friday.theglobeandmail.com - August 2 at 5:57 PMAntibe Therapeutics Announces Amendment to Warrant Termsnz.finance.yahoo.com - June 15 at 7:13 AMAntibe Therapeutics Inc. (ATE.TO)finance.yahoo.com - June 3 at 10:22 AMAntibe Therapeutics Announces Strategic Sale of Citagenix Subsidiaryfinance.yahoo.com - May 2 at 8:51 AMATE.TO: First Human PK/PD Studies Underway in Otenaproxesul’s Post-Operative Pain Program…msn.com - February 16 at 1:22 PMATE.TO: First Human PK/PD Studies Underway in Otenaproxesul’s Post-Operative Pain Program…finance.yahoo.com - February 16 at 1:22 PMAntibe Therapeutics Inc. (TSE:ATE) Given Consensus Rating of "Buy" by Analystsmarketbeat.com - January 2 at 6:21 AMIs There An Opportunity With Antibe Therapeutics Inc.'s (TSE:ATE) 23% Undervaluation?finance.yahoo.com - December 27 at 9:38 AM Get Antibe Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for ATE and its competitors with MarketBeat's FREE daily newsletter. Email Address Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed! (Ad)Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put in place starting today, so “they” don’t get your money tomorrow. Click here for your free guide ATE Media Mentions By Week ATE Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ATE News Sentiment▼0.000.41▲Average Medical News Sentiment ATE News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ATE Articles This Week▼00▲ATE Articles Average Week Get Antibe Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for ATE and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Sirona Biochem News Resverlogix News Reunion Neuroscience News Aeterna Zentaris News IMV News Kane Biotech News Ceapro News Quest PharmaTech News Innovotech News Hemostemix News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (TSE:ATE) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarThese AI trades triggered this morning (545% return)Prosper Trading Academytop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressFed launches fourth dollar overhaulStansberry ResearchThe AI stock to buy right nowStockEarningsExposed: 10 CENT Crypto to Explode April 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Antibe Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
